Medidata, Circuit Clinical partner in decentralized clinical trial push

By Nick Taylor

- Last updated on GMT

(Tetiana Lazunova/iStock via Getty Images Plus)
(Tetiana Lazunova/iStock via Getty Images Plus)

Related tags: Medidata, Circuit Clinical, Decentralized trials, Virtual clinical trials, COVID-19, Data management

Integrated research organization Circuit Clinical will standardize its decentralized operations with Medidata’s RAVE and myMedidata technological offerings.

Medidata has partnered with integrated research organization Circuit Clinical to step up its decentralized clinical trial (DCT) offering.

Circuit Clinical, like other integrated research organizations, is focused on enabling patients to choose clinical research as a care option. Now, Circuit Clinical is investing to expand its DCT network to meet the rise in demand for decentralized trials.

The COVID-19 pandemic has propelled interest in and adoption of DCTs. As the landscape of clinical trials has evolved, scalable, flexible, and intuitive solutions are necessary. The next era of clinical trials is underway, and the fuel for success will be improvements in patient, site, and sponsor experiences​,” said Kelly McKee, vice president of patient registries and recruitment at Medidata.

Through the alliance, Circuit Clinical will standardize its DCT sites on Medidata’s RAVE and myMedidata technologies. Today, Circuit Clinical has a network of 90 doctors across more than 30 sites and is working to grow its operation.

Investors are supporting the expansion. With Medidata contributing to a $27m financing round, Circuit Clinical plans to expand its network to cover 500 physician investigators and 15m patients.

McKee foresees the use of Medidata technologies at Circuit Clinical sites resulting in faster study starts and improved patient recruitment while enabling optimization to any level of study decentralization.

OSP_MedidataCircuit_KK
Kelly McKee, vice president of patient registries and recruitment, Medidata

It is critical for patients, sponsors, and sites to have a single platform for all their clinical trial needs​,” said McKee. “Implementing the right level of decentralization using an end-to-end, unified, and secure platform allows sponsors to improve chances of trial success, increase protocol adherence and safety monitoring, and bring value to patients, sites, and sponsors​.”   

Circuit Clinical will invite its participating healthcare systems to join myMedidata Clinical Trial Patient Registries. In doing so, the partners aim to raise awareness of, and access to, clinical trial opportunities.

Study subjects will have the opportunity to rate and review their experiences of participating in clinical trials using Circuit Clinical’s TrialJourney system. The partners are aiming to improve the experiences of patients and, in doing so, make it easier to retain patients. Today, Circuit Clinical claims a 93% retention rate across all projects.

Circuit Clinical’s current offering covers cardiovascular disease, diabetes, women’s health, kidney disease, digestive diseases, rheumatoid arthritis, cancer, COVID-19, and other therapeutic areas.

Related news

Show more

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us

Products

View more

Webinars